Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Burckart

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|August 19, 2008
Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantationDiana M Girnita, Gilbert Burckart, Adriana Zeevi
Journal of Clinical Pharmacology|December 17, 2004
Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patientsJaya Pisupati, Ashok Jain, Gilbert Burckart, et al.
Journal of Clinical Pharmacology|September 19, 2017
Bridging Adult Experience to Pediatrics in Oncology Drug DevelopmentRuby Leong, Hong Zhao, Gregory Reaman, et al.
Journal of Clinical Pharmacology|July 3, 2002
Evaluation of renal function in transplant patients on tacrolimus therapySangeeta Agarwala, Emma Culligan, Ashok Jain, et al.
American Journal of Therapeutics|December 1, 1994
Continuous Infusion Ranitidine in Postoperative Pediatric Liver Transplant Patients: Effects on Intragastric pH, Gastrointestinal Bleeding and Metabolic AlkalosisRobert J. Dimand, Gilbert Burckart, Waldo Concepcion, et al.
Pharmacogenomics|December 21, 2012
Improving clinical trial sampling for future research - an international approach: outcomes and next steps from the DIA future use sampling workshop 2011Amelia Wall Warner, Karina L Bienfait, Marianna Bledsoe, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 13, 2004
HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejectionAlin L Girnita, Kenneth R McCurry, Aldo T Iacono, et al.
Nature Reviews. Drug Discovery|November 1, 2011
Clinical pharmacology as a cornerstone of orphan drug developmentEdward D Bashaw, Shiew-Mei Huang, Timothy R Coté, et al.
Pediatrics|April 27, 2019
Research Gaps in Primary Pediatric HypertensionPerdita Taylor-Zapata, Carissa M Baker-Smith, Gilbert Burckart, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 8, 2005
HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunctionAlin L Girnita, Rene Duquesnoy, Samuel A Yousem, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|August 19, 2008
Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantationDiana M Girnita, Gilbert Burckart, Adriana Zeevi
Journal of Clinical Pharmacology|December 17, 2004
Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patientsJaya Pisupati, Ashok Jain, Gilbert Burckart, et al.
Journal of Clinical Pharmacology|September 19, 2017
Bridging Adult Experience to Pediatrics in Oncology Drug DevelopmentRuby Leong, Hong Zhao, Gregory Reaman, et al.
Journal of Clinical Pharmacology|July 3, 2002
Evaluation of renal function in transplant patients on tacrolimus therapySangeeta Agarwala, Emma Culligan, Ashok Jain, et al.
American Journal of Therapeutics|December 1, 1994
Continuous Infusion Ranitidine in Postoperative Pediatric Liver Transplant Patients: Effects on Intragastric pH, Gastrointestinal Bleeding and Metabolic AlkalosisRobert J. Dimand, Gilbert Burckart, Waldo Concepcion, et al.
Pharmacogenomics|December 21, 2012
Improving clinical trial sampling for future research - an international approach: outcomes and next steps from the DIA future use sampling workshop 2011Amelia Wall Warner, Karina L Bienfait, Marianna Bledsoe, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 13, 2004
HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejectionAlin L Girnita, Kenneth R McCurry, Aldo T Iacono, et al.
Nature Reviews. Drug Discovery|November 1, 2011
Clinical pharmacology as a cornerstone of orphan drug developmentEdward D Bashaw, Shiew-Mei Huang, Timothy R Coté, et al.
Pediatrics|April 27, 2019
Research Gaps in Primary Pediatric HypertensionPerdita Taylor-Zapata, Carissa M Baker-Smith, Gilbert Burckart, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 8, 2005
HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunctionAlin L Girnita, Rene Duquesnoy, Samuel A Yousem, et al.
Pageof 2